Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
88.98
+1.73 (1.98%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Spyre Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $129 → $116 | Buy | Maintains | $129 → $116 | +30.37% | Aug 29, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $130 | Buy | Reiterates | $130 | +46.10% | Aug 27, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $140 → $121 | Buy | Reiterates | $140 → $121 | +35.99% | Aug 26, 2026 |
| Wedbush | Wedbush | Buy Maintains $130 → $123 | Buy | Maintains | $130 → $123 | +38.23% | Aug 26, 2026 |
| BTIG | BTIG | Buy Reiterates $132 → $121 | Buy | Reiterates | $132 → $121 | +35.99% | Aug 26, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $90 → $115 | Buy | Maintains | $90 → $115 | +29.24% | Aug 26, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $135 → $127 | Buy | Maintains | $135 → $127 | +42.73% | Aug 26, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $123 | Buy | Maintains | $123 | +38.23% | Aug 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.